Cargando…
Molecular pathology underlying the robustness of cancer stem cells
Intratumoral heterogeneity is tightly associated with the failure of anticancer treatment modalities including conventional chemotherapy, radiation therapy, and molecularly targeted therapy. Such heterogeneity is generated in an evolutionary manner not only as a result of genetic alterations but als...
Autores principales: | Yoshida, Go J., Saya, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024885/ https://www.ncbi.nlm.nih.gov/pubmed/33869685 http://dx.doi.org/10.1016/j.reth.2021.02.002 |
Ejemplares similares
-
Therapeutic strategies targeting cancer stem cells
por: Yoshida, Go J., et al.
Publicado: (2015) -
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
por: Yoshida, Go J.
Publicado: (2020) -
Targeting of cancer stem cells by differentiation therapy
por: Arima, Yoshimi, et al.
Publicado: (2020) -
The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells
por: Yoshida, Go J.
Publicado: (2021) -
Pathological Bases for a Robust Application of Cancer Molecular Classification
por: Diaz-Cano, Salvador J.
Publicado: (2015)